Preliminary results of French polls reveal defeat of two leading partiesWorld April 23, 22:49
Macron, Le Pen lead in first round of French election — TVWorld April 23, 21:33
Russian Foreign Ministry slams OSCE car incident in Donbass as 'provocation'Russian Politics & Diplomacy April 23, 19:41
Macron winning presidential polls among French living in US, Canada — TVWorld April 23, 19:12
French nationals in Moscow expect presidential polls to bring changes to their countryWorld April 23, 18:01
French presidential hopefuls cast ballots in first round of electionWorld April 23, 15:52
OSCE staff member dies in car blast in DonbassWorld April 23, 13:55
Presidential hopeful Emmanuel Macron gets in line to voteWorld April 23, 12:26
First candidates cast ballots in presidential election in FranceWorld April 23, 11:26
KALUGA, June 5. /TASS/. A new pharmaceutical plant, Nearmedic Pharma, located on the territory of a major innovation and industrial Kaluga region, in central Russia, is starting manufacturing medicines.
The project worth $73 million is implemented in cooperation with the national holding company Nearmedic and the Russian Corporation of Nanotechnologies, the press service of Nearmedic Plus told TASS.
The new plant complies with international standards GMP, ISO and FDA. The total annual output reaches up to 100 million medical products, including anti-viral medications.
"The plant is unique as the whole cycle from the synthesis of incoming substances to manufacturing of finished pharma products comes in the framework of one production unit and the product range is the company’s innovations," the press service said.
All the pharmaceutical companies in Russia's Kaluga region are united in a single pharma cluster which now consists of 54 companies.